Evidence for population variation in TSC1 and TSC2 gene expression

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Jentarra, Garilyn M ^a   Rice, Stephen G ^a   Olfers, Shannon ^a   Saffen, David ^b   Narayanan, Vinodh ^a,c  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b FUDAN UNIVERSITY   (China)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; TSC1 PROTEIN; TUBERIN; UNCLASSIFIED DRUG; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL ISOLATION; CONTROLLED STUDY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN CELL; LEUKOCYTE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUBEROUS SCLEROSIS COMPLEX; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; METABOLISM; MUTATION; PHENOTYPE; TUBEROUS SCLEROSIS;

GENE EXPRESSION; GENETIC VARIATION; GENETICS, POPULATION; HUMANS; LEUKOCYTES; MUTATION; PHENOTYPE; RNA, MESSENGER; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 79951856253     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-29     Document Type: Article

References (54)

1. The European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315. 10.1016/0092-8674(93)90618-Z, 8269512, The European Chromosome 16 Tuberous Sclerosis Consortium.
2. Gomez MRSJ, Whittemore VH. Tuberous Sclerosis Complex 1999, New York: Oxford University Press, 3.
3. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808. 10.1126/science.277.5327.805, 9242607.
4. Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, Wheless JW, Baumgartner JE, Roa BB, Wilson CM, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007, 9:88-100. 10.1097/GIM.0b013e31803068c7, 17304050.
5. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001, 68:64-80. 10.1086/316951, 1234935, 11112665.
6. Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR, Cheadle JP. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999, 64:1305-1315. 10.1086/302381, 1377866, 10205261.
7. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991, 615:125-127. 10.1111/j.1749-6632.1991.tb37754.x, 2039137.
8. Sampson JR, Scahill SJ, Stephenson JB, Mann L, Connor JM. Genetic aspects of tuberous sclerosis in the west of Scotland. J Med Genet 1989, 26:28-31. 10.1136/jmg.26.1.28, 1015532, 2918523.
9. Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S, Halley D, van den Ouweland A. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005, 13:731-741. 10.1038/sj.ejhg.5201402, 15798777.
10. Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999, 53:1384-1390.
11. Weiner DM, Ewalt DH, Roach ES, Hensle TW. The tuberous sclerosis complex: a comprehensive review. J Am Coll Surg 1998, 187:548-561. 10.1016/S1072-7515(98)00239-7, 9809574.
12. Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int 2004, 66:924-934. 10.1111/j.1523-1755.2004.00838.x, 15327383.
13. Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr Nephrol 2005, 20:854-857. 10.1007/s00467-004-1795-3, 15856327.
14. Hohman DW, Noghrehkar D, Ratnayake S. Lymphangioleiomyomatosis: A review. Eur J Intern Med 2008, 19:319-324. 10.1016/j.ejim.2007.10.015, 18549932.
15. Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 2004, 63:1236-1242.
16. Tucker T, Friedman JM. Pathogenesis of hereditary tumors: beyond the "two-hit" hypothesis. Clin Genet 2002, 62:345-357. 10.1034/j.1399-0004.2002.620501.x, 12431247.
17. Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, Sims K, MacCollin M, Louis DN, Ramesh V. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 2001, 69:493-503. 10.1086/321972, 1235480, 11468687.
18. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996, 59:400-406. 1914733, 8755927.
19. Green AJ, Sepp T, Yates JR. Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation. Hum Genet 1996, 97:240-243. 10.1007/BF02265273, 8566961.
20. Sepp T, Yates JR, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996, 33:962-964. 10.1136/jmg.33.11.962, 1050793, 8950679.
21. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 2005, 8:1727-1734. 10.1038/nn1566, 16286931.
22. van Slegtenhorst M, Verhoef S, Tempelaars A, Bakker L, Wang Q, Wessels M, Bakker R, Nellist M, Lindhout D, Halley D, van den Ouweland A. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. J Med Genet 1999, 36:285-289. 1734341, 10227394.
23. Rok P, Kasprzyk-Obara J, Domanska-Pakiela D, Jozwiak S. Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation. Med Sci Monit 2005, 11:CR230-234.
24. Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, Sampson JR, Cheadle JP. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 1997, 6:2155-2161. 10.1093/hmg/6.12.2155, 9328481.
25. Jansen AC, Sancak O, D'Agostino MD, Badhwar A, Roberts P, Gobbi G, Wilkinson R, Melanson D, Tampieri D, Koenekoop R, et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol 2006, 60:528-539. 10.1002/ana.21037, 17120248.
26. Bundey S, Evans K. Tuberous sclerosis: a genetic study. J Neurol Neurosurg Psychiatry 1969, 32:591-603. 10.1136/jnnp.32.6.591, 496595, 5364733.
27. Nevin NC, Pearce WG. Diagnostic and genetical aspects of tuberous sclerosis. J Med Genet 1968, 5:273-280. 10.1136/jmg.5.4.273, 1468678, 5713638.
28. O'Connor SE, Kwiatkowski DJ, Roberts PS, Wollmann RL, Huttenlocher PR. A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation. Neurology 2003, 61:409-412.
29. Northrup H, Wheless JW, Bertin TK, Lewis RA. Variability of expression in tuberous sclerosis. J Med Genet 1993, 30:41-43. 10.1136/jmg.30.1.41, 1016232, 8423606.
30. Mayer K, Goedbloed M, van Zijl K, Nellist M, Rott HD. Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis. J Med Genet 2004, 41:e64. 10.1136/jmg.2003.010835, 1735780, 15121792.
31. Lyczkowski DA, Conant KD, Pulsifer MB, Jarrett DY, Grant PE, Kwiatkowski DJ, Thiele EA. Intrafamilial phenotypic variability in tuberous sclerosis complex. J Child Neurol 2007, 22:1348-1355. 10.1177/0883073807307093, 18174550.
32. Au KS, Ward CH, Northrup H. Tuberous sclerosis complex: disease modifiers and treatments. Curr Opin Pediatr 2008, 20:628-633. 10.1097/MOP.0b013e328318c529, 19005330.
33. Humphrey A, Higgins JN, Yates JR, Bolton PF. Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits. Neurology 2004, 62:795-798.
34. Kwiatkowski D. TSC1, TSC2, TSC3? Or mosaicism?. Eur J Hum Genet 2005, 13:695-696. 10.1038/sj.ejhg.5201412, 15912141.
35. Kwiatkowska J, Wigowska-Sowinska J, Napierala D, Slomski R, Kwiatkowski DJ. Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med 1999, 340:703-707. 10.1056/NEJM199903043400905, 10053179.
36. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 2003, 113:149-153.
37. Buckland PR. Allele-specific gene expression differences in humans. Hum Mol Genet 2004, 13(Spec No 2):R255-260. 10.1093/hmg/ddh227, 15358732.
38. Knight JC. Allele-specific gene expression uncovered. Trends Genet 2004, 20:113-116. 10.1016/j.tig.2004.01.001, 15049300.
39. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic variation in human gene expression. Science 2002, 297:1143. 10.1126/science.1072545, 12183620.
40. Norton N, Williams NM, Williams HJ, Spurlock G, Kirov G, Morris DW, Hoogendoorn B, Owen MJ, O'Donovan MC. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet 2002, 110:471-478. 10.1007/s00439-002-0706-6, 12073018.
41. Yan H, Dobbie Z, Gruber SB, Markowitz S, Romans K, Giardiello FM, Kinzler KW, Vogelstein B. Small changes in expression affect predisposition to tumorigenesis. Nat Genet 2002, 30:25-26. 10.1038/ng799, 11743581.
42. Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005, 280:32618-32624. 10.1074/jbc.M504942200, 16046395.
43. Dermitzakis ET. From gene expression to disease risk. Nat Genet 2008, 40:492-493. 10.1038/ng0508-492, 18443581.
44. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP. Allelic variation in gene expression is common in the human genome. Genome Res 2003, 13:1855-1862. 10.1101/gr.885403, 403776, 12902379.
45. Pinheiro H, Bordeira-Carrico R, Seixas S, Carvalho J, Senz J, Oliveira P, Inacio P, Gusmao L, Rocha J, Huntsman D, et al. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010, 19:943-952. 10.1093/hmg/ddp537, 19965908.
46. Rockman MV, Wray GA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002, 19:1991-2004.
47. Pastinen T, Hudson TJ. Cis-acting regulatory variation in the human genome. Science 2004, 306:647-650. 10.1126/science.1101659, 15499010.
48. Caux-Moncoutier V, Pages-Berhouet S, Michaux D, Asselain B, Castera L, De Pauw A, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Houdayer C. Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study. Eur J Hum Genet 2009, 17:1471-1480. 10.1038/ejhg.2009.89, 2986693, 19471317.
49. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics 2005, 15:693-704. 10.1097/01.fpc.0000178311.02878.83, 16141795.
50. Gartler SM, Goldman MA. Biology of the X chromosome. Curr Opin Pediatr 2001, 13:340-345. 10.1097/00008480-200108000-00010, 11717560.
51. Butler MG. Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet 2009, 26:477-486. 10.1007/s10815-009-9353-3, 2788689, 19844787.
52. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005, 37:19-24. 10.1038/ng1494, 15624019.
53. Southam L, Rodriguez-Lopez J, Wilkins JM, Pombo-Suarez M, Snelling S, Gomez-Reino JJ, Chapman K, Gonzalez A, Loughlin J. An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum Mol Genet 2007, 16:2226-2232. 10.1093/hmg/ddm174, 17616513.
54. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, Attar-Cohen H, Ingle C, Beazley C, Gutierrez Arcelus M, Sekowska M, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250. 10.1126/science.1174148, 2867218, 19644074.